Vanda Pharmaceuticals to Participate in UBS Global Life Sciences Conference

Sep 14, 2011, 19:00 ET from Vanda Pharmaceuticals Inc.

ROCKVILLE, Md., Sept. 14, 2011 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced that Mihael H. Polymeropoulos, M.D., Vanda's President and CEO will deliver a corporate presentation at the UBS Global Life Sciences Conference in New York City on Tuesday, September 20, 2011 at 12:30 p.m. Eastern Time.  

Dr. Polymeropoulos' presentation at the UBS Global Life Sciences Conference will be available live on Vanda's corporate website, where it also will be archived for 30 days.  To access the presentation, log on to http://www.vandapharma.com and click on the Presentations option in the Investor Relations section. Please connect to the website several minutes prior to the start of the live presentation.

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com.

Company Contact: Cristina Murphy Communications Manager Vanda Pharmaceuticals Inc. (240) 599-4500 cristina.murphy@vandapharma.com

SOURCE Vanda Pharmaceuticals Inc.



RELATED LINKS

http://www.vandapharma.com